This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Nonpeptide
There is no page with the exact title "Nonpeptide". The search results for "Nonpeptide" are displayed below. You can create a page titled Nonpeptide (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Nonpeptide inhibitor (51 bytes)
1: List of pages with the keyword Nonpeptide inhibitor - Category:Nonpeptide (41 bytes)
1: List of pages with the keyword Nonpeptide
Page text matches
- 2uue (7,808 bytes)
24: ... crystal structures. This method therefore allows nonpeptide fragments to be identified without the requiremen... - 2v11 (6,677 bytes)
27: ...ical trials. Our primary aim was to develop novel nonpeptide inhibitors. Based on the available structural inf...
29: ...ructure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.,Rahuel J... - 2v12 (6,692 bytes)
27: ...ical trials. Our primary aim was to develop novel nonpeptide inhibitors. Based on the available structural inf...
29: ...ructure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.,Rahuel J... - 2v10 (6,677 bytes)
27: ...ical trials. Our primary aim was to develop novel nonpeptide inhibitors. Based on the available structural inf...
29: ...ructure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.,Rahuel J... - 2v0z (6,660 bytes)
27: ...ical trials. Our primary aim was to develop novel nonpeptide inhibitors. Based on the available structural inf...
29: ...ructure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.,Rahuel J... - 1b6j (11,642 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1b6k (11,713 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1b6l (11,690 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1b6m (11,683 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1b6p (11,700 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1hvh (11,461 bytes)
2: ==NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS...
26: Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibito... - 1hvr (9,854 bytes)
2: ==RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS== - 1z1h (11,757 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1z1r (11,759 bytes)
24: ...ion state isostere and either an acyclic peptide, nonpeptide, or another macrocycle. These cyclic analogues ar... - 1ztz (11,666 bytes)
26: From nonpeptide toward noncarbon protease inhibitors: metallacarb... - 1b8y (5,845 bytes)
28: ...human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivit... - 1c86 (4,726 bytes)
24: ...sed to optimize a relatively weak, nonphosphorus, nonpeptide general PTP inhibitor (2-(oxalyl-amino)-benzoic a...
26: ... design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosi... - 1c87 (4,714 bytes)
24: ...sed to optimize a relatively weak, nonphosphorus, nonpeptide general PTP inhibitor (2-(oxalyl-amino)-benzoic a...
26: ... design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosi... - 1c88 (4,729 bytes)
24: ...sed to optimize a relatively weak, nonphosphorus, nonpeptide general PTP inhibitor (2-(oxalyl-amino)-benzoic a...
26: ... design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosi... - 1caq (5,869 bytes)
28: ...human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivit...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
